Icons / Logo / Facebook Created with Sketch. Icons / Logo / Google Created with Sketch. Icons / Logo / ORCID Created with Sketch. Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
  • References (5)
  • Citations (0)
Published on Jul 1, 2019in Obesity 3.97
William H. Dietz97
Estimated H-index: 97
(GW: George Washington University),
Christine Gallagher2
Estimated H-index: 2
(GW: George Washington University)
Published on Jul 1, 2019in Obesity 3.97
Robert F. Kushner46
Estimated H-index: 46
(NU: Northwestern University),
Deborah B. Horn3
Estimated H-index: 3
(University of Texas at Austin)
+ 10 AuthorsMagdalena Pasarica17
Estimated H-index: 17
(UCF: University of Central Florida)
Published on Jan 1, 2018in Obesity 3.97
Lee M. Kaplan52
Estimated H-index: 52
(Harvard University),
Angela K Golden1
Estimated H-index: 1
+ 10 AuthorsKj Tomaszewski1
Estimated H-index: 1
Objective ACTION (Awareness, Care, and Treatment in Obesity maNagement) examined obesity-related perceptions, attitudes, and behaviors among people with obesity (PwO), health care providers (HCPs), and employer representatives (ERs). Methods A total of 3,008 adult PwO (BMI ≥ 30 by self-reported height and weight), 606 HCPs, and 153 ERs completed surveys in a cross-sectional design. Results Despite several weight loss (WL) attempts, only 23% of PwO reported 10% WL during the previous 3 years. Man...
Published on Jul 1, 2017in Diabetes Care 15.27
Fangjian Guo11
Estimated H-index: 11
(UTMB: University of Texas Medical Branch),
W. Garvey54
Estimated H-index: 54
(UAB: University of Alabama at Birmingham)
OBJECTIVE To assess the ability of medication-assisted weight loss to prevent diabetes as a function of the baseline weighted Cardiometabolic Disease Staging (CMDS) score. RESEARCH DESIGN AND METHODS We pooled data from 3,040 overweight and obese participants in three randomized controlled trials—CONQUER, EQUIP, and SEQUEL—assessing efficacy and safety of phentermine/topiramate extended release (ER) for weight loss. In these double-blind phase III trials, overweight/obese adult patients were tre...
Published on Jul 1, 2016in Endocrine Practice 4.15
W. Garvey54
Estimated H-index: 54
Jeffrey I. Mechanick38
Estimated H-index: 38
+ 6 AuthorsRaymond Plodkowski3
Estimated H-index: 3
Objective: Development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and the American College of Endocrinology (ACE) Board of Trustees and adheres to published AACE protocols for the standardized production of clinical practice guidelines (CPGs). Methods: Recommendations are based on diligent review of clinical evidence with transparent incorporation of subjective factors. Results: There are 9 broad clinical questions with 123 ...
Cited By0